Reinventing Drug Safety with AI-Powered Data

Sable is here to reinvent drug safety through cutting-edge AI-driven data and predictive analytics. Empowering researchers with state-of-the-art tools that integrate and expand on multimodal evidence, we propel the development of safe and effective medicines. Join us in shaping the future of safe and effective drug discovery.

Join the Waitlist

Enhancing domain expertise with artificial intelligence

Sable combines innovative data foundations with a flexible, expert-led approach, to simplify complex decisions for users.

Multimodal data foundations.
Sable extracts valuable information from sparse and complex sources, producing a depth of varied and proprietary datasets.

Flexible platform.
Context-responsive approaches adapt to various safety scenarios with different requirements, across indication-types, modalities and development stages.

Driven by the experts.
Our technology empowers scientists to make better decisions, with fine-grained controls and prioritised evidence.

Clear actions.
Interpretable predictions, explanations and recommendations simplify complex questions into actionable next-steps.

Our mission

Advanced Understanding, Safer Medicines

Our mission is to empower researchers with effective and user-friendly tools that harness the most relevant scientific evidence, accelerating the development of safe and effective medicines for patients who need them.

Newsroom

3 New Hires at Sable

We have had 3 amazing people join the Sable team all of whom are starting to help us form and shape our product and data strategies. We're happy to introduce Clare, Olly, and Camille!

Announcing our £1.5m investment

Sable announces the successful completion of an oversubscribed £1.5 million pre-seed funding round. This investment will enable the team to grow, and accelerate the AI-enhanced data foundations and platform for predicting drug safety.

Join the team

We're hiring! Take a look at our open positions if you're interested in being part of a team building the future of science utilising world-leading technology.

Company

Team

Scientific Advisory Board

Investors

Careers

Open Positions

Updates

Fundraising Announcement

Privacy

Company

Team

Scientific Advisory Board

Investors

Careers

Open Positions

Updates

Fundraising Announcement

Privacy

Company

Team

Scientific Advisory Board

Investors

Careers

Open Positions

Updates

Fundraising Announcement

Privacy

Enhancing domain expertise with artificial intelligence

Enhancing domain expertise with artificial intelligence

Enhancing domain expertise with artificial intelligence

Sable combines innovative data foundations with a flexible, expert-led approach, to simplify complex decisions for users.

Sable combines innovative data foundations with a flexible, expert-led approach, to simplify complex decisions for users.

Sable combines innovative data foundations with a flexible, expert-led approach, to simplify complex decisions for users.

Multimodal data foundations. Sable extracts valuable information from sparse and complex sources, producing a depth of varied and proprietary datasets.

Flexible platform. Context-responsive approaches adapt to various safety scenarios with different requirements, across indication-types, modalities and development stages.

Driven by the experts. Our technology empowers scientists to make better decisions, with fine-grained controls and prioritised evidence.

Clear actions. Interpretable predictions, explanations and recommendations simplify complex questions into actionable next-steps.

Our mission

Our mission

Advanced Understanding, Safer Medicines

Advanced Understanding, Safer Medicines

Advanced Understanding, Safer Medicines

Our mission is to empower researchers with effective and user-friendly tools that harness the most relevant scientific evidence, accelerating the development of safe and effective medicines for patients who need them.

Our mission is to empower researchers with effective and user-friendly tools that harness the most relevant scientific evidence, accelerating the development of safe and effective medicines for patients who need them.

Multimodal data foundations.
Sable extracts valuable information from sparse and complex sources, producing a depth of varied and proprietary datasets.

Flexible platform.
Context-responsive approaches adapt to various safety scenarios with different requirements, across indication-types, modalities and development stages.

Driven by the experts.
Our technology empowers scientists to make better decisions, with fine-grained controls and prioritised evidence.

Clear actions.
Interpretable predictions, explanations and recommendations simplify complex questions into actionable next-steps.